1. Zhuang W#, Liu SL#, Xi SY#, Feng YN, Wang K, Abduwali T, Liu P, Zhou XJ, Zhang L*, Dong XZ*.Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: Efficacies and mechanisms.J Ethnopharmacol.2023.307.116272.SCI |
2. Chen C#, Xu YJ#, Zhang SR, Wang XH, Hu Y, Guo DH, Zhou XJ, Zhu WY, Wen AD, Tan QR, Dong XZ*, Liu P*.MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1.Heliyon.2023.9(3).e14265.SCI |
3. 杨萍,鲁松,董宪喆*,张兰*.药品综合评价方法研究进展.中国药物警.2022.19(7).803-806.核心期刊 |
4. 鲁松,杨黎,董宪喆*,张兰*.雷贝拉唑治疗反流性食管炎疗效及安全性的Meta分析.中国药物警戒.2022.19(6).649-653.核心期刊 |
5. Yang L#, Dong XZ#, Cui XH, Liu JM, Liu WN, Zhang L*.Comparison of the efficacy and safety of levetiracetam and phenytoin in the treatment of established status epilepticus: A systematic review and meta-analysis.J Clin Neurosci.2021.89.422-429.SCI |
6. Dong XZ, Zhao ZR, Hu Y, Lu YP, Liu P*, Zhang L*.LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis.Gastric Cancer.2020.23(2).260-272.SCI |
7. Zhou X#, Wang J#, Lu Y, Chen C, Hu Y, Liu P*, Dong X*.Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis. J Ethnopharmacol.2020.252.112615.SCI |
8. Dong XZ, Wang DX, Zhang TY, Liu X, Liu P, Hu Y*.Identification of protein targets for the antidepressant effects of Kai-Xin-San in Chinese medicine using isobaric tags for relative and absolute quantitation.Neural Regen Res.2020.15(2).302-310.SCI |
9. Dong XZ, Song Y, Lu YP, Hu Y, Liu P*, Zhang L*.Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway.J Nat Med.2019.777-788.73(4).SCI |